Enteric Softgel Capsules Market Report 2025

This Enteric Softgel Capsules market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The enteric softgel capsules market size has grown strongly in recent years. It will grow from $2.34 billion in 2024 to $2.46 billion in 2025 at a compound annual growth rate (CAGR) of 5.23%. The growth observed during the historical period can be attributed to a rising demand for pharmaceuticals, heightened focus on health and nutrition, an increase in R&D activities, growing demand for soft gel health supplements, and a greater awareness among consumers about preventive healthcare.

The enteric softgel capsules market size is expected to see steady growth in the next few years. It will grow to $2.99 billion in 2029 at a compound annual growth rate (CAGR) of 4.97%. Projected growth during the forecast period is expected to be driven by an increased focus on clinical trials, greater reliance on online platforms, an emphasis on preventive healthcare, a rising prevalence of nutrition disorders, and growing awareness. Key trends anticipated include technological advancements, a stronger emphasis on clinical trials, innovations in manufacturing processes, increasing partnerships, and product development.

The rising prevalence of nutrition disorders is expected to drive the growth of the enteric softgel capsules market. Nutritional disorders arise from imbalances in nutrient intake, such as deficiencies or excesses of essential vitamins, minerals, proteins, fats, and carbohydrates. Factors such as poor dietary habits, sedentary lifestyles, limited access to nutritious food, increasing consumption of processed foods, and socio-economic barriers contribute to the growing incidence of these disorders. Enteric softgel capsules address these issues by delivering essential nutrients with a protective coating that shields them from stomach acid, enabling targeted release in the intestines for optimal absorption. This improves nutrient bioavailability and supports digestive health and nutritional balance. For example, a 2023 report by the Food and Agriculture Organization highlighted that severe food insecurity impacted 2.8% of the ECA population in 2022, affecting approximately 26.2 million people, an increase from the previous year. As a result, the increasing prevalence of nutrition disorders is driving market growth.

Leading companies in the enteric softgel capsule market are innovating with plant-based technologies to enhance product performance and appeal. Plant-based enteric softgels, made from plant-derived materials instead of animal-based gelatin, feature enteric coatings for targeted intestinal release. In October 2022, Sirio Pharma Co. introduced EnteriClear, a plant-based solution designed to protect acid-sensitive ingredients from stomach degradation without traditional coatings. This technology ensures improved bioavailability, intestinal release, reduced discomfort, and offers unique benefits such as being non-GMO, gluten-free, and sugar-free. With a stable, clear shell that does not require cold chain storage, EnteriClear is ideal for nutraceutical brands.

In August 2024, Kühne Holding AG, a Switzerland-based transportation and logistics company, acquired Aenova Group GmbH from BC Partners for an undisclosed amount. This strategic acquisition aims to expand Kühne Holding AG’s investment portfolio by incorporating healthcare and pharmaceutical assets, expected to deliver strong financial returns and long-term growth. Aenova Group GmbH, based in Germany, specializes in the production of various dosage forms, including tablets, capsules, and sterile liquids.

Major players in the enteric softgel capsules market are BASF SE, Thermo Fisher Scientific Inc., United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd.

North America was the largest region in the enteric softgel capsules market in 2024. The regions covered in enteric softgel capsules report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the enteric softgel capsules market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Enteric softgel capsules are specially designed with a protective coating that prevents their contents from being exposed to stomach acid. This allows the capsules to dissolve in the small intestine, ensuring targeted release and absorption. This technology is widely used for products such as probiotics, fish oil, and medications, protecting sensitive ingredients and minimizing stomach irritation.

The primary types of enteric softgel capsules are gelatin and non-gelatin capsules. Gelatin capsules are small, soluble containers made from gelatin, designed to hold powdered or liquid substances for oral consumption. These capsules are distributed through various channels, including supermarkets and hypermarkets, pharmacies and drug stores, and online platforms. They are used in multiple applications, such as antacid and antiflatulent preparations, anti-inflammatory drugs, antibiotic and antibacterial drugs, cough and cold remedies, health supplements, vitamins, dietary supplements, and other therapeutic purposes. These products serve diverse end users, including pharmaceutical, nutraceutical, and cosmeceutical companies, as well as the food industry.

The enteric softgel capsules market research report is one of a series of new reports that provides enteric softgel capsules market statistics, including enteric softgel capsules industry global market size, regional shares, competitors with an enteric softgel capsules market share, detailed enteric softgel capsules market segments, market trends and opportunities, and any further data you may need to thrive in the enteric softgel capsules industry. This enteric softgel capsules market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The enteric softgel capsules market consists of sales of products including probiotics, pain relievers, digestive enzymes, and vitamins. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.